肠道微生物组组成与健康克罗恩病一级亲属未来发病相关
本研究为前瞻性队列研究,纳入3483名克罗恩病患者健康一级亲属,用16S核糖体RNA测序和机器学习构建微生物组风险评分(MRS)。在验证队列中,以发现队列MRS中位数为阈值,MRS模型的风险比为2.24(95%CI 1.03-4.84;P=.04),并可在发病前5年识别将发生克罗恩病的个体(曲线下面积>0.65)。
要点
- 在验证队列中,以发现队列MRS中位数为阈值,MRS模型的风险比为2.24(95%CI 1.03-4.84;P=.04)。
- MRS具有时间效度,可识别发病前5年内发生克罗恩病的个体(曲线下面积>0.65)。
- 对MRS贡献最大的5个类群包括Ruminococcus torques、Blautia、Colidextribacter、Oscillospiraceae中一个未培养的属级类群和Roseburia。
核心结论
- 本研究首次证明肠道微生物组组成与克罗恩病未来发病相关,并提示肠道微生物组是克罗恩病发病机制的贡献因素。
研究设计与样本
- 前瞻性队列研究,纳入3483名克罗恩病患者健康一级亲属,以16S核糖体RNA测序分析肠道微生物组组成。
- 采用机器学习方法定义与克罗恩病未来发病相关的微生物特征,并在独立验证队列中评估模型表现。
主要发现
- 在验证队列中,以发现队列MRS中位数为阈值,MRS模型的风险比为2.24(95%CI 1.03-4.84;P=.04)。
- MRS具有时间效度,可识别发病前5年内发生克罗恩病的个体(曲线下面积>0.65)。
- 对MRS贡献最大的5个类群包括Ruminococcus torques、Blautia、Colidextribacter、Oscillospiraceae中一个未培养的属级类群和Roseburia。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The cause of Crohn's disease (CD) is unknown, but the current hypothesis is that microbial or environmental factors induce gut inflammation in genetically susceptible individuals, leading to chronic intestinal inflammation. Case-control studies of patients with CD have cataloged alterations in the gut microbiome composition; however, these studies fail to distinguish whether the altered gut microbiome composition is associated with initiation of CD or is the result of inflammation or drug treatment. METHODS: In this prospective cohort study, 3483 healthy first-degree relatives (FDRs) of patients with CD were recruited to identify the gut microbiome composition that precedes the onset of CD and to what extent this composition predicts the risk of developing CD. We applied a machine learning approach to the analysis of the gut microbiome composition (based on 16S ribosomal RNA sequencing) to define a microbial signature that associates with future development of CD. The performance of the model was assessed in an independent validation cohort. RESULTS: In the validation cohort, the microbiome risk score (MRS) model yielded a hazard ratio of 2.24 (95% confidence interval, 1.03-4.84; P = .04), using the median of the MRS from the discovery cohort as the threshold. The MRS demonstrated a temporal validity by capturing individuals that developed CD up to 5 years before disease onset (area under the curve > 0.65). The 5 most important taxa contributing to the MRS included Ruminococcus torques, Blautia, Colidextribacter, an uncultured genus-level group from Oscillospiraceae, and Roseburia. CONCLUSION: This study is the first to demonstrate that gut microbiome composition is associated with future onset of CD and suggests that gut microbiome is a contributor in the pathogenesis of CD.
引用
- Raygoza Garay JA, Turpin W, Lee SH, et al. Gut Microbiome Composition Is Associated With Future Onset of Crohn's Disease in Healthy First-Degree Relatives. Gastroenterology. 2023. PMID: 37263307. doi:10.1053/j.gastro.2023.05.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。